4 results
56 Cognitive Intra-Individual Variability Profiles of a Spanish Speaking Population Living with HIV and Injection Drug Use
- Jeremy A Feiger, Rachael L. Snyder, Alec J Miller, Carmen A Davila, Kim G Carrasco, Kirk Dombrowski, Roberto Abadie, Anibal Valentin, Samodha Fernando, John T West, Charles Wood, Sydney J Bennett, Kathy S Chiou
-
- Journal:
- Journal of the International Neuropsychological Society / Volume 29 / Issue s1 / November 2023
- Published online by Cambridge University Press:
- 21 December 2023, pp. 52-53
-
- Article
-
- You have access Access
- Export citation
-
Objective:
Individuals living with HIV may experience cognitive difficulties or marked declines known as HIV-Associated Neurocognitive Disorder (HAND). Cognitive difficulties have been associated with worse outcomes for people living with HIV, therefore, accurate cognitive screening and identification is critical. One potentially sensitive marker of cognitive impairment which has been underutilized, is intra-individual variability (IIV). Cognitive IIV is the dispersion of scores across tasks in neuropsychological assessment. In individuals living with HIV, greater cognitive IIV has been associated with cortical atrophy, poorer cognitive functioning, with more rapid declines, and greater difficulties in daily functioning. Studies examining the use of IIV in clinical neuropsychological testing are limited, and few have examined IIV in the context of a single neuropsychological battery designed for culturally diverse or at-risk populations. To address these gaps, this study aimed to examine IIV profiles of individuals living with HIV and who inject drugs, utilizing the Neuropsi, a standardized neuropsychological instrument for Spanish speaking populations.
Participants and Methods:Spanish speaking adults residing in Puerto Rico (n=90) who are HIV positive and who inject drugs (HIV+I), HIV negative and who inject drugs (HIV-I), HIV positive who do not inject drugs (HIV+), or healthy controls (HC) completed the Neuropsi battery as part of a larger research protocol. The Neuropsi produces 3 index scores representing cognitive domains of memory, attention/memory, and attention/executive functioning. Total battery and within index IIV were calculated by dividing the standard deviation of T-scores by mean performance, resulting in a coefficient of variance (CoV). Group differences on overall test battery mean CoV (OTBMCoV) were investigated. To examine unique profiles of index specific IIV, a cluster analysis was performed for each group.
Results:Results of a one-way ANOVA indicated significant between group differences on OTBMCoV (F[3,86]=6.54, p<.001). Post-hoc analyses revealed that HIV+I (M=.55, SE=.07, p=.003), HIV-I (M=.50, SE=.03, p=.001), and HIV+ (M=.48, SE=.02, p=.002) had greater OTBMCoV than the HC group (M=.30, SE=.02). To better understand sources of IIV within each group, cluster analysis of index specific IIV was conducted. For the HIV+ group, 3 distinct clusters were extracted: 1. High IIV in attention/memory and attention/executive functioning (n=3, 8%); 2. Elevated memory IIV (n=21, 52%); 3. Low IIV across all indices (n=16, 40%). For the HIV-I group, 2 distinct clusters were extracted: 1. High IIV across all 3 indices (n=7, 24%) and 2. Low IIV across all 3 indices (n=22, 76%). For the HC group, 3 distinct clusters were extracted: 1. Very low IIV across all 3 indices (n=5, 36%); 2. Elevated memory IIV (n=6, 43%); 3. Elevated attention/executive functioning IIV with very low attention/memory and memory IIV (n=3, 21%). Sample size of the HIV+I group was insufficient to extract clusters.
Conclusions:Current findings support IIV in the Neuropsi test battery as clinically sensitive marker for cognitive impairment in Spanish speaking individuals living with HIV or who inject drugs. Furthermore, the distinct IIV cluster types identified between groups can help to better understand specific sources of variability. Implications for clinical assessment in prognosis and etiological considerations are discussed.
29 Human Immunodeficiency Virus (HIV) Status, Injection Drug Use, and Cognitive Effects in a Spanish-Speaking Population
- Rachael L. Snyder, Alec J. Miller, Jeremy A. Feiger, Carmen A. Davila, Kim G. Carrasco, Kirk Dombrowski, Roberto Abadie, Anibal Valentin, Samodha Fernando, John T. West, Charles Wood, Sydney J. Bennett, Kathy S. Chiou
-
- Journal:
- Journal of the International Neuropsychological Society / Volume 29 / Issue s1 / November 2023
- Published online by Cambridge University Press:
- 21 December 2023, pp. 442-443
-
- Article
-
- You have access Access
- Export citation
-
Objective:
Injection drug use is a significant public health crisis with adverse health outcomes, including increased risk of human immunodeficiency virus (HIV) infection. Comorbidity of HIV and injection drug use is highly prevalent in the United States and disproportionately elevated in surrounding territories such as Puerto Rico. While both HIV status and injection drug use are independently known to be associated with cognitive deficits, the interaction of these effects remains largely unknown. The aim of this study was to determine how HIV status and injection drug use are related to cognitive functioning in a group of Puerto Rican participants. Additionally, we investigated the degree to which type and frequency of substance use predict cognitive abilities.
Participants and Methods:96 Puerto Rican adults completed the Neuropsi Attention and Memory-3rd Edition battery for Spanish-speaking participants. Injection substance use over the previous 12 months was also obtained via clinical interview. Participants were categorized into four groups based on HIV status and injection substance use in the last 30 days (HIV+/injector, HIV+/non-injector, HIV/injector, HIV-/non-injector). One-way analysis of variance (ANOVA) was conducted to determine differences between groups on each index of the Neuropsi battery (Attention and Executive Function; Memory; Attention and Memory). Multiple linear regression was used to determine whether type and frequency of substance use predicted performance on these indices while considering HIV status.
Results:The one-way ANOVAs revealed significant differences (p’s < 0.01) between the healthy control group and all other groups across all indices. No significant differences were observed between the other groups. Injection drug use, regardless of the substance, was associated with lower combined attention and memory performance compared to those who inject less than monthly (Monthly: p = 0.04; 2-3x daily: p < 0.01; 4-7x daily: p = 0.02; 8+ times daily: p < 0.01). Both minimal and heavy daily use predicted poorer memory performance (p = 0.02 and p = 0.01, respectively). Heavy heroin use predicted poorer attention and executive functioning (p = 0.04). Heroin use also predicted lower performance on tests of memory when used monthly (p = 0.049), and daily or almost daily (2-6x weekly: p = 0.04; 4-7x daily: p = 0.04). Finally, moderate injection of heroin predicted lower scores on attention and memory (Weekly: p = 0.04; 2-6x weekly: p = 0.048). Heavy combined heroin and cocaine use predicted worse memory performance (p = 0.03) and combined attention and memory (p = 0.046). HIV status was not a moderating factor in any circumstance.
Conclusions:As predicted, residents of Puerto Rico who do not inject substances and are HIVnegative performed better in domains of memory, attention, and executive function than those living with HIV and/or inject substances. There was no significant difference among the affected groups in cognitive ability. As expected, daily injection of substances predicted worse performance on tasks of memory. Heavy heroin use predicted worse performance on executive function and memory tasks, while heroin-only and combined heroin and cocaine use predicted worse memory performance. Overall, the type and frequency of substance is more predictive of cognitive functioning than HIV status.
Contrasted hydrological systems of the Peruvian Amazon induce differences in growth patterns of the silver arowana, Osteoglossum bicirrhosum
- Fabrice Duponchelle, Adela Ruiz Arce, Annelore Waty, Jacques Panfili, Jean-François Renno, Filomena Farfan, Aurea Garcia-Vasquez, Fred Chu Koo, Carmen Garcia Davila, Gladys Vargas, Almilcar Ortiz, Ricardo Pinedo, Jesus Nuñez
-
- Journal:
- Aquatic Living Resources / Volume 25 / Issue 1 / January 2012
- Published online by Cambridge University Press:
- 17 April 2012, pp. 55-66
- Print publication:
- January 2012
-
- Article
- Export citation
-
In Amazonian fisheries, the silver arowana, Osteoglossum bicirrhosum (Cuvier 1829) is heavily exploited for human consumption as an adult, and for the aquarium trade as a small juvenile (yolk sac juvenile mainly). The periodicity of annuli formation on otoliths and growth variability of the silver arowana were studied in different river river-basins of the Peruvian Amazon between 2006 and 2009. Transverse stained sections of 606 individual otoliths were analysed from four different river-basins, the Amazonas, Ucayali, Napo and Putumayo, of which 554 could be interpreted. These belonged to 274 females ranging from 15 to 91 cm (standard length) and 280 males ranging from 30 to 91 cm. In addition, yolk sac juveniles of known age were collected to improve growth modelling. Monthly proportions of stained otolith edges validated the formation of a single annulus per year in two different river-basins with lagged hydrological cycles: the Amazonas-Ucayali and the Putumayo. Stained growth mark counts resulted in a longevity estimate of at least 16 years for the silver arowana in the Peruvian Amazon. This fish grew quickly during the first two years, and asymptotic growth was reached after four to five years, except in the Putumayo where it was reached slightly earlier. Results showed no significant growth dimorphism between sexes within basins, but indicated significant growth differences among river basins. Silver arowanas measured, on average, between 38 and 40 cm at the end of their first year. Length-at-age differences among river basins increased with age to reach over 14 cm (and >3 kg) after 7 years between the faster and slower growing populations (Amazonas and Putumayo, respectively). The growth differences observed emphasize the need for further investigation on the population structure of this species as, although these differences might merely be phenotypic responses to contrasted environmental conditions, they could alternatively reflect the existence of several populations with distinct genetic and life history characteristics. The consequences of such differences would be very important for the management and conservation of this fragile and extensively exploited species.
How many meals a day to minimize cannibalism when rearing larvae of the Amazonian catfish Pseudoplatystoma punctifer? The cannibal’s point of view
- Etienne Baras, Dustin V. Silva del Aguila, Grace V. Montalvan Naranjos, Rémi Dugué, Fred Chu Koo, Fabrice Duponchelle, Jean-François Renno, Carmen Garcia-Dávila, Jesus Nuñez
-
- Journal:
- Aquatic Living Resources / Volume 24 / Issue 4 / October 2011
- Published online by Cambridge University Press:
- 03 November 2011, pp. 379-390
- Print publication:
- October 2011
-
- Article
- Export citation
-
Meal frequency is a key parameter in fish larviculture, especially in highly cannibalistic species. Knowledge of the biological bases of cannibalism (growth capacity of cannibals, morphological constraints on cannibalism, prey size preference) can help predicting the risks of cannibalism for different feeding schedules under culture conditions. This study relied on the day-by-day analysis of prey size preference and bioenergetics of individual cannibals of the catfish Pseudoplatystoma punctifer (8–65 mm standard length, SL, 0.5–400 mg dry mass, DM) at 28.5 °C under 12L:12D. The results were equated with the ontogenetic variations of morphological factors (head and mouth width) and feed efficiency of larvae feeding on Artemia nauplii, in order to calculate the risks of cannibalism among fish fed 2–7 daily meals. The predation capacities of P. punctifer were highest at 8 mm SL and decreased in larger fish (largest prey = 86% and 70% SL in fish of 8 and >30 mm SL, respectively). Cannibals of increasing size preferred increasingly smaller prey relative to their own size, but also to their predation capacities. These morphological and behavioural constraints were largely compensated for by bioenergetics performance. Cannibals consumed high daily food rations (as high as 171 and 29% DM in fish <1 and >300 mg DM, respectively), exhibited high gross conversion efficiencies (0.50–0.55 and about 0.70, in fish <1 and >30 mg DM, respectively), and grew rapidly (90 and 18% DM day-1 in fish <1 and >300 mg DM, respectively). The growth advantage of cannibals over siblings fed Artemia nauplii was decisive, except for high meal frequencies (6–7 daily meals). This study supports the view that the risk of cannibalism and adequate feeding strategies can be largely predicted in a particular fish species if the morphological, behavioural and bioenergetics bases of cannibalism are examined altogether in an ontogenetic perspective.